FHC
MDGL icon

First Horizon Corporation’s Madrigal Pharmaceuticals MDGL Stock Holding History

First Horizon Corporation’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.8K Buy
48
+2
+4% +$1.02K ﹤0.01% 895
2026
Q1 		$24.1K Sell
46
-22
-32% -$10.5K ﹤0.01% 845
2025
Q4 		$39.6K Sell
68
-7
-9% -$3.58K ﹤0.01% 741
2025
Q3 		$34.4K Buy
+75
New +$28K ﹤0.01% 700

Other funds holding MDGL

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return
SAM
Seelaus Asset Management Chatham, New Jersey $142M AUM 48.54% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

First Horizon Corporation's MDGL Position: Q2 2026 in Review

First Horizon Corporation increased its Madrigal Pharmaceuticals (MDGL) stake by 4.3% in Q2 2026, buying an estimated $1.02K and bringing the position to 48 shares worth $25.8K. The position accounts for ﹤0.01% of the portfolio, ranked #895.

First Horizon Corporation first reported a position in MDGL in Q3 2025 and has held it in 4 quarters since. The position peaked at $39.6K in Q4 2025. 34 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • First Horizon Corporation held 48 shares of Madrigal Pharmaceuticals worth $25.8K as of Q2 2026.
  • First Horizon Corporation bought 2 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $1.02K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #895 holding.
  • First Horizon Corporation first reported a position in Madrigal Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • First Horizon Corporation's Madrigal Pharmaceuticals position peaked at $39.6K in Q4 2025.
  • 34 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.